论文部分内容阅读
为探讨腺苷脱氨酶(ADA)和IV型胶原蛋白(IV-C)在肝脏疾病中的诊断意义,作者将122例标本分成正常对照组、HBsAg阳性肝功能试验正常组、HBsAg阳性肝功能试验异常组、肝硬化组和肝癌组分别进行ADA和IV-C测定并分析结果。结果表明,ADA的阳性率在HBsAg阳性组明显高于肝硬化和肝癌组;而VI-C的阳性率以肝硬化和肝癌组为高。ADA的检测有助于监测轻微的肝脏病变而IV-C检测有助于肝纤维化进程观察和疗效评估。
In order to explore the diagnostic value of adenosine deaminase (ADA) and type IV collagen (IV-C) in liver diseases, 122 patients were divided into normal control group, HBsAg-positive liver function test group, HBsAg-positive liver function Abnormalities in the test group, liver cirrhosis group and liver cancer group were measured ADA and IV-C and analyzed the results. The results showed that the positive rate of ADA in HBsAg positive group was significantly higher than in cirrhosis and liver cancer group; while the positive rate of VI-C in cirrhosis and liver cancer group was high. ADA test can help detect minor liver lesions and IV-C test can help observe the progress of liver fibrosis and efficacy evaluation.